Scarica l'app Stockscreener
4.16
0.95%
-0.04
Dopo l'orario di chiusura:
4.17
0.010
+0.24%
Trisalus Life Sciences Inc Borsa (TLSI) Ultime notizie
TriSalus Life Sciences Warrants (TLSIW) Hold Steady Near Support in Quiet TradingAndrews Pitchfork - newsline.com
TLSI Q1 2026 Earnings: EPS Surprise of 118.86% Drives Stock HigherAnalyst Drop Coverage - newsline.com
TriSalus Life Sciences (TLSI) Q1 2026 Earnings: Surprise Profitability as EPS Beats Estimates by 118.86% - newsline.com
TriSalus Life Sciences (TLSI) Gains 2.88% as Stock Approaches Key Resistance LevelWave Extension - newsline.com
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc.TLSI - PR Newswire
TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer - Stock Titan
TriSalus Life Sciences Inc. (TLSI) Q1 2026 Earnings: Strong EPS Surprise Driven by Operational ProgressFree Cash Flow Trends - newsline.com
TLSI INVESTOR ALERT: Holzer & Holzer, LLC Investigation of TriSalus Life Sciences, Inc. - GlobeNewswire
TriSalus Life Sciences, Inc. (TLSI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-06-03 | Bronstein, Gewirtz & Grossman, LLC Encourages TriSalus Life Sciences, Inc. (TLSI) Shareholders to Inquire about Securities Investigation | NDAQ:TLSI | Press Release - Stockhouse
TLSI News | TRISALUS LIFE SCIENCES INC (NASDAQ:TLSI) - ChartMill
TSLI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating TriSalus Life Sciences, Inc. (TLSI) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages TriSalus Life Sciences, Inc. (TLSI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2026-06-01 | Bronstein, Gewirtz & Grossman, LLC Encourages TriSalus Life Sciences, Inc. (TLSI) Stockholders to Inquire about Securities Investigation | NDAQ:TLSI | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TriSalus Life Sciences, Inc. (TLSI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
TLSI Q1 2026 Earnings: Surprise Profit Beats Analyst Estimates, Shares RallySurprise Factor Analysis - newsline.com
Number of shareholders of TriSalus Life Sciences, Inc. – NASDAQ:TLSI - TradingView
TriSalus Life Sciences, Inc. (TLSI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TriSalus Life Sciences Q1 2026 Earnings: Surprise EPS Profit of $0.03 Beats Estimates by 118.9%Forward Guidance Trends - newsline.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating TriSalus Life Sciences, Inc. (TLSI) And Encourages Stockholders to Connect - ACCESS Newswire
TriSalus Life Sciences, Inc. (TLSI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TriSalus Life Sciences, Inc. (TLSI) Investigation: Bronstein, Gew - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TriSalus Life Sciences, Inc. (TLSI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
TriSalus Life Sciences (TLSI) Falls Over 5% as Stock Tests Key Support Near $3.10Stop Hunt - The Legal Advocate
Bronstein, Gewirtz & Grossman, LLC Encourages TriSalus Life Sciences, Inc. (TLSI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Investigation launched into TriSalus Life Sciences after Q1 revenue misses estimates and cuts full-year guidance - Pluang
TLSI Q1 2026 Earnings: EPS Surprises Positively Despite No Revenue, Stock DeclinesProfit Warning Alert - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating TriSalus Life Sciences, Inc. (RLSI) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating TriSalus Life - The National Law Review
TriSalus Life Sciences (TLSI) Q1 2026 Earnings: EPS Surges Past Expectations, Yet Stock SlipsEBITDA Margin Trends - Newser
TLSI (TLSI) Securities Fraud InvestigationLevi & Korsinsky - Morningstar
Certain Stock Options of TriSalus Life Sciences, Inc. are subject to a Lock-Up Agreement Ending on 22-MAY-2026. - marketscreener.com
Certain Restricted Stock Units of TriSalus Life Sciences, Inc. are subject to a Lock-Up Agreement Ending on 22-MAY-2026. - marketscreener.com
Certain Stock Warrants of TriSalus Life Sciences, Inc. are subject to a Lock-Up Agreement Ending on 22-MAY-2026. - marketscreener.com
James Pallotta reports 5.2% stake in TriSalus Life Sciences (TLSI) - Stock Titan
38 startups join Innosphere life-sciences incubator - BizWest
Levi & Korsinsky Announces Investigation of Securities Claims Against TLSI (TLSI) - GlobeNewswire
TriSalus (TLSI) CCO reports 543-share tax-withholding sale, retains over 125K shares - Stock Titan
TLSI Investor Alert: Levi & Korsinsky Investigates TLSI (TLSI) for Potential Securities Fraud - Business Wire
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
TriSalus Life Sciences, Inc. Common Stock (TLSI) Stock Price Today & Analysis - Gotrade
TLSI Insider Buying Surge: 5 Executives Purchase $1.3M in Stock - Meyka
TriSalus Life Sciences Director Purchased Shares Worth Over $1.5M - TradingView
TriSalus Life Sciences (TLSI) director buys 10,000 shares in open market - Stock Titan
Director Mats Wahlstrom boosts TriSalus (TLSI) stake with 60,000-share open-market buy - Stock Titan
TriSalus (TLSI) director and LLC add 610K shares in open-market buys - Stock Titan
TriSalus (TLSI) CEO Mary Szela adds 39,682 shares in open-market stock purchase - Stock Titan
TriSalus (TLSI) CFO adds 7,100 shares in open-market purchase - Stock Titan
Earnings call transcript: TriSalus Life Sciences Q1 2026 sees stock gain despite revenue dip By Investing.com - Investing.com Australia
Earnings call transcript: TriSalus Life Sciences Q1 2026 sees stock gain despite revenue dip - Investing.com UK
TLSI SHAREHOLDER INVESTIGATION: SueWallSt Investigates TLSI for Possible Securities Law Violations - PR Newswire
1.21%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):